Fang Fuquan, Jin Jing, Pi Yongmin, Guo Shaohui, Li Yuhong, Zhu Shengmei, Kang Xianhui
Department of Anesthesiology, the First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, 310003 China.
Zhejiang Center for Clinical Laboratory, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014 China.
Anesthesiol Perioper Sci. 2023;1(1):7. doi: 10.1007/s44254-023-00003-9. Epub 2023 Mar 13.
SARS-CoV-2 have become widespread worldwide since the outbreak. Respiratory function deteriorates rapidly in critically ill patients infected with SARS-CoV-2. Endotracheal intubation is an indispensable therapeutic measure during the development of the disease. This study was intended to describe the experience of endotracheal intubation from front-line anesthesiologists and clinical prognosis of patients infected with Coronavirus disease-19 (COVID-19).
Fourteen critical patients infected with COVID-19 who underwent endotracheal intubation were included in this study. We collate and analyze the blood gas results before and after tracheal intubation of patients and clinical prognostic indicators such as length of stay and. mortality. The experience of anesthesiologists who intubated patients has also been recorded in detail.
Patients had a mean time of 10.6 days from initial symptoms to endotracheal intubation. Most intubated patients had one or more underlying conditions: hypertension (8, 57.14%), diabetes (5, 35.71%), and cardiovascular and cerebrovascular diseases (2, 14.29%). The oxygenation index increased significantly after intubation compared with before intubation (148.80 ± 42.25 vs 284.43 ± 60.17 < 0.001). 85.72% of patients required extra-corporeal membrane oxygenation (ECMO) due to inability to maintain oxygen saturation with standard therapeutic measures. Two patients underwent lung transplantation because their lungs were essentially nonfunctional, and they recovered well after surgery. As of this writing, all patients were discharged after satisfactory recovery.
Reasonable selection of intubation timing is particularly important. It is crucial to increase the patient's oxygen supply and reduce oxygen consumption as much as possible during endotracheal intubation. In addition, the personal protective measures of medical personnel participating in treatment should be scientific and standardized.
自疫情爆发以来,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)已在全球广泛传播。感染SARS-CoV-2的危重症患者呼吸功能迅速恶化。气管插管是疾病发展过程中不可或缺的治疗措施。本研究旨在描述一线麻醉医生进行气管插管的经验以及新型冠状病毒肺炎(COVID-19)患者的临床预后。
本研究纳入了14例接受气管插管的COVID-19危重症患者。我们整理并分析了患者气管插管前后的血气结果以及住院时间和死亡率等临床预后指标。还详细记录了为患者插管的麻醉医生的经验。
患者从出现初始症状到气管插管的平均时间为10.6天。大多数插管患者有一种或多种基础疾病:高血压(8例,57.14%)、糖尿病(5例,35.71%)以及心脑血管疾病(2例,14.29%)。与插管前相比,插管后氧合指数显著升高(148.80±42.25 vs 284.43±60.17,P<0.001)。85.72%的患者因标准治疗措施无法维持氧饱和度而需要体外膜肺氧合(ECMO)。2例患者因肺部基本无功能而接受了肺移植,术后恢复良好。截至撰写本文时,所有患者均在康复情况良好后出院。
合理选择插管时机尤为重要。气管插管期间尽可能增加患者的氧供并减少氧耗至关重要。此外,参与治疗的医务人员的个人防护措施应科学规范。